Protein Biomarker Models for Oncology Risk Assessment and Treatment Monitoring
In this webinar you’ll learn how the power of large-scale proteomics can be leveraged for multiple divergent applications in the field of oncology ‒ from monitoring the cardiotoxic effects of chemotherapy treatment to developing blood-based protein-only tests for stratifying lung cancer susceptibility.
Watch this webinar to discover how:
- Proteomic risk scores can be used to identify high risk patients and monitor for adverse effects
- To analyze thousands of proteins to develop cancer susceptibility models
High-throughput proteomics can inform and impact patients' standard of care